Further comparison of ubiquinol and cytochrome c terminal oxidases  by Musser, Siegfried M. et al.
December 1993 Volume 335, number 2, 296-298 FEBS 13315 
0 1993 Federation of European Biochemical Societies 00145793/93/$6.00 
Commentary Response 
Further comparison of ubiquinol and cytochrome c terminal oxidases 
Siegfried M. Musser, Michael H.B. Stowell, Sunney I. Ghan* 
Arthur Amos Noyes Laboratory of Chemical Physics, 127-72, California Institute of Technology, Pasadena, CA 91125, USA 
Received 14 October 1993 
Ubiquinol oxidase; Cytochrome c oxidase; Electron transfer; Proton pumping; Q-loop 
In the preceeding commentary, Haltia reflects on our 
view presented in [l] that the ubiquinol and cytochrome 
c terminal oxidases are likely to utilize different electron 
transfer and proton translocation mechanisms. We 
would like to take this opportunity to clarify our posi- 
tion on some of the issues that he discusses. 
Haltia compares the structure and function of sub- 
unit II of the two families of terminal oxidases, the 
ubiquinol oxidases and the cytochrome c oxidases. 
While structure prediction in general is hardly a mature 
field, hydrophobicity calculations are relatively accu- 
rate for predicting the number and approximate loca- 
tion of transmembrane helices in a membrane protein. 
However, such predictions are inaccurate at times [2,3] 
and, moreover, say virtually nothing about the extra- 
membraneous domains. To predict that two polypep- 
tides have a similar structure on the basis of hydropho- 
bicity calculations is pushing the technique beyond the 
limits of its capabilities. As pointed out in our minire- 
view [l], the Cu, site and part or all of the residues 
responsible for the binding of cytochrome c are thought 
to be located in the extra-membraneous domain of sub- 
unit II of the cytochrome c oxidases. In contrast, due 
to the extreme hydrophobic nature of the physiological 
substrate ubiquinol-8, the ubiquinol binding site(s) is 
(are) expected to exist in the transmembrane region of 
the ubiquinol oxidase complexes as is analogously ob- 
served in the structures of bacterial photosynthetic reac- 
tion centers. If a ubiquinol binding domain exists on 
subunit II of the cytochrome bo, complex, as has been 
suggested by a number of studies [4,5], the substrate 
oxidizing domains of the two families of terminal oxi- 
dases would exist in different three-dimensional loca- 
tions and protein environments of subunit II. Thus, the 
subunit II’s of the two families of oxidases could have 
either very different folding patterns to accommodate 
the different substrates or they could have very similar 
overall folding patterns for evolutionary reasons. We 
note that the 10% sequence identity of subunit II of the 
Escherichia coli cytochrome bo, complex and the Para- 
coccus denitrz@ans cytochrome au, complex is well 
below what Doolittle terms the ‘twilight zone’ (15-25% 
sequence identity), and accordingly, these polypeptides 
are unlikely to be evolutionarily related based on se- 
quence comparison alone [6]. 
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Haltia supports his argument for similar overall fold- 
ing patterns for subunit II of the two families of oxi- 
dases with experiments in which up to six residues in a 
fragment of the E. coli quinol oxidase subunit II were 
mutated in an attempt to create a Cu, site [7,8]. It 
remains to be shown that the peptide conformations 
with and without the mutated residues are basically the 
same. Virtually any polypeptide into which cysteines 
and histidines are introduced will bind copper, most 
likely in an altered conformation because of the nucleat- 
ing effect of the metal ions. Van der Oost and coworkers 
found that mutation of these six residues in the holoen- 
zyme resulted in severely inhibited growth and the mu- 
tant enzyme was unstable upon purification [7]. These 
results indicate that binding of copper to subunit II 
produces a substantial disruption of the structure of the 
complex and that significant conformational changes 
occur upon incorporation of the metal site. Finally, we 
note that a type I copper site has been introduced into 
E. coli thioredoxin in an environment of very different 
secondary structure than that found in blue-copper pro- 
teins indicating that spectroscopically identical metal 
sites do not necessarily reflect similar polypeptide fold- 
ing patterns. In addition, mutated residues are not nec- 
essarily utilized as hoped, that is, as ligands to the intro- 
duced metal site [9]. 
We agree with Haltia that the ubiquinol oxidases are 
the more ancient of the two families of terminal oxidases 
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but for a different reason. As pointed out in [I], the 
cytochrome bo3 complex combines the electron transfer 
processes of both the cytochrome bc, and cytochrome 
au, complexes and thus is similar to the cytochrome 
bc,lcytochrome clcytochrome aa, supercomplexes i o- 
lated from p1 deni@z3cuns [ 1 O] and thermophilic bacillus 
PS3 [ll]. We assume that the supercomplexes are the 
more evolved version of terminal oxidases due to their 
greater complexity and their greater efficiency at energy 
transduction. Haltia’s argument hat the ubiquinol oxi- 
dase is the more ancient form because it has a lower 
copper content and that copper was not generally avail- 
able until oxygen appeared is difficult to accept. In wild- 
type E. coli, the cytochrome bo, complex is expressed 
under conditions of high oxygen tension (the cyto- 
chrome d complex is expressed under conditions of low 
oxygen tension and does not contain copper [ 12]), which 
would imply that the cytochrome bo, complex evolved 
well after the appearance of oxygen, and thus copper, 
in the biosphere. 
Haltia also argues that ‘the ubiquinol oxidases are 
likely to have a less efficient, and probably simpler, 
electron gating mechanism than the cytochrome c oxi- 
dases, in contrast to the complex mechanism proposed 
in [ 11’. A redox loop as proposed in [l] only requires 
control of electron transfer since proton flow follows to 
or from the more accessible proton pool (i.e. aqueous 
medium). However, a proton pump as found in the 
cytochrome c oxidases requires control of both electron 
transfer and proton conduction through the enzyme 
complex as well as efficient coupling between these two 
processes (redox linkage). Proton conduction is much 
more difficult to control than electron transfer, and 
thus, we argue that the mechanism presented in [I] is a 
simpler proton translocation mechanism than that 
found in the cytochrome c oxidases. This line of reason- 
ing also suggests that the ubiquinol oxidases comprise 
the more primitive terminal oxidase family. 
The midpoint potentials of the redox centers in the 
cytochrome bo, complex are still a matter of debate. In 
[l], we used recent room temperature data which indi- 
cate that the midpoint potentials of cytochrome b, cyto- 
chrome o3 and Cu, are about 60, 220, and 400 mV, 
respectively [13,14]. Other investigators have found the 
cytochrome b midpoint potential to be about 140 mV 
[15] or as high as 250 mV [16]. The latter value was 
obtained by EPR measurements at 77 K, so the ob- 
served midpoint potential may be much different than 
the more physiologically relevant room temperature 
midpoint potential. The room temperature potential of 
cytochrome b appears to be in the 50-150 mV range 
which is still > 100 mV less than the potential of the 
low-spin cytochrome of the cytochrome c oxidases. A 
higher potential for cytochrome b than we assumed in 
[l] does not disprove our model, however, for we know 
nothing about the ubiquinone/ubisemiquinone and 
ubisemiquinone/ubiquinol redox couples operative in 
the cytochrome bo3 system; that is, we do not know the 
extent to which the cytochrome bo, complex stabilizes 
ubisemiquinone. Rationalizations of complex func- 
tional processes based on midpoint potentials are ad- 
mittedly quite weak since the important parameters are 
physiological solution potentials about which we know 
little. Our use of midpoint potentials in [l] was not 
intended to prove our model but rather to illustrate an 
alternative method of interpreting data concerning the 
function of the cytochrome bo, complex. 
Electron transfer from cytochrome b to cytochrome 
o3 in the context of the model presented in [l] is an 
electron leak which results in a slip in the proton 
translocation process. Such an observed electron trans- 
fer has been observed in CO-flash experiments [17,18] 
and may result from the non-physiological nature of the 
fully-reduced cytochrome bo, complex in its CO-bound 
and -unbound forms. More importantly, however, the 
model presented in [ 1] requires the presence of a ubiqui- 
none molecule at the QB site. Such a bound ubiquinone 
molecule can have a profound effect on the open elec- 
tron transfer pathways due to redox as well as confor- 
mational mteractions. To our knowledge, ubiquinone 
was not present in the CO-flash experiments mentioned 
above so these data do not disprove the model in [l]. We 
note that a model of the full turnover cycle of the cyto- 
chrome bo, complex may require electron transfer be- 
tween cytochrome b and the binuclear center. 
Due to the similarity between the Q-loop of the cyto- 
chrome bc, complex and that which we propose for the 
cytochrome bo, complex, one can predict the manner in 
which various ubiquinone analogs will affect the activ- 
ity of the cytochrome bo, complex. For example, 2- 
heptyl-4-hydroxyquinoline N-oxide (HQNO) and 5-n- 
undecyl-6-hydroxy-4,7-dioxobenzothiazole (UHDBT) 
have been found to inhibit the activity of the cyto- 
chrome bo, complex with Ki’S of 0.8 and 0.3 mM, re- 
spectively [19]. These inhibitors are also potent inhib- 
itors of the cytochrome bc, complex, and bind at differ- 
ent sites on this enzyme. HQNO inhibits ubiquinone 
binding to center N [20] whereas UHDBT inhibits ubiq- 
uinol binding to center P [21]. Thus, we predict that 
HQNO inhibits ubiquinone binding to the QB site and 
UHDBT inhibits ubiquinol binding to the QA site ac- 
cording to our Q-loop model for the cytochrome bo, 
complex. HQNO has been found to modify the spectro- 
scopic behavior of cytochrome o, and inhibit reoxida- 
tion of this cytochrome by oxygen [15], results that 
Haltia terms ‘anomalous’. These results could be ex- 
plained by conformational interactions between the QB 
site and cytochrome o, but this explanation is unlikely 
due to proximity of the QB site to cytochrome b and the 
absence of any spectral perturbations to this cyto- 
chrome. However, HQNO has been reported to affect 
both center P and center N at high inhibitor to protein 
ratios [20], and thus, it is conceivable that HQNO binds 
to both the QA and QB sites at the high concentrations 
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used in [15]. Under these conditions, then, it is feasible 
that there are conformational interactions between the 
QA site and the high-spin heme but not the low-spin 
heme. 
There obviously exists much that we do not yet un- 
derstand about the family of terminal ubiquinol oxi- 
dases. We have raised some intriguing possibilities that 
can only be settled by further experimentation, and we 
hope that this discussion aids in directing such investi- 
gations. 
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